Skip to content

Effect of Haemdialysis Membrane Permeability on Inflammatory Indices and Arterial Stiffness: A Comparison between 2 Dialyzers Composing of Identical Material but with Different Flux Characterics.

Effect of Haemdialysis Membrane Permeability on Inflammatory Indices and Arterial Stiffness: A Comparison between 2 Dialyzers Composing of Identical Material but with Different Flux Characterics.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000658
Enrollment
Unknown
Registered
2005-09-13
Start date
2005-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart and Blood Vessel Diseases

Interventions

Two groups:24 weels haemodialysis with high-flux dialyzer versis 24 weeks haemodialysis with low-flux dialyzer

Sponsors

CUHK
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Anuric (urine output < 100 ml/day); 2. Age between 18 and 75 years old; 3. On hemodialysis treatment with bicarbonate dialysate, for at least 3 months; 4. On a dialyzer reuse program using polysulfone dialyzer for at least 3 months; 5. Stable with no change in dialysis prescription for at least 3 months preceding enrolment; 6. Vascular access functioning properly; 7. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindication for dialyzer reuse; 2. Active infection, inflammatory disease, ongoing malignancy or active phase immune disease; 3. Patient with immunosuppressive medication; 4. Recently measured C-reactive protein level > 50 mg/L; 5. Predictable survival < 1 year; 6. Planned renal transplantation within the 1-year study period.

Design outcomes

Primary

MeasureTime frame
Comparing the arterial pulse wave velocity and the inflammatory indices between the 2 groups.;

Secondary

MeasureTime frame
Comparing the biochemical markers between the 2 groups.;

Countries

China

Contacts

Public ContactCheng Yuk Lun
www.na@163.com+852 2689 3023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026